Latest News and Press Releases

- Acquired Intelligent Fingerprinting Limited and its proprietary drugs of abuse screening technology - - Announced new additions to Board of Directors and name change to Intelligent Bio Solutions...

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients...

- Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European Aviation Authority regulations - NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio...

NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions,...

- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University of Newcastle campus for the high-tech...

- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant Funding Award from Australian Government - -...

 – Announced Pre-Submission Package sent to the FDA for its Glucose Biosensor Test –  – Clinical Validation Study Results for SARS CoV2 Ab Test –  – Evaluating site locations for build out of...

NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...

NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...

NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at...